Basic info
Industry
biotechnology research
Sectors
Biotechnology
DDR
Phase I
PARP inhibitor
Therapeutics
drug development
Pharmaceutical
oncology
biotech
Date founded
2017
Funding rounds raised
Total raised
$25M
from 7 investors over 7 rounds
C
Cybrexa Therapeutics raised $25M on March 10, 2021
Investors: Elm Street Ventures, Advantage Capital and HighCape Partners
C
Cybrexa Therapeutics raised $13M on June 21, 2019
Investors: HighCape Partners
C
Cybrexa Therapeutics raised undisclosed on March 2, 2018
Investors: Advantage Capital
C
Cybrexa Therapeutics raised undisclosed on March 2, 2018
Investors: Advantage Capital
C
Cybrexa Therapeutics raised $6M on June 16, 2017
Investors: HighCape Partners